Literature DB >> 29103740

Reconstruction design before tumour resection: A new concept of through-and-through cheek defect reconstruction.

Zhao-Jian Gong1, Zhen-Hu Ren2, Kai Wang1, Hong-Yu Tan1, Sheng Zhang1, Han-Jiang Wu3.   

Abstract

OBJECTIVE: To explore a new method of reconstruction of through-and-through cheek defects and to evaluate this method's efficacy and patient prognosis.
MATERIALS AND METHODS: This retrospective study included 70 patients who underwent reconstruction of through-and-through cheek defects. The surgical approach, design of facial skin incisions, selection and design of flaps, postoperative quality of life and prognosis of patients were recorded and reported.
RESULTS: Postoperative quality of life gradually increased over time, and the mean scores of University of Washington Quality of Life (UW-QOL) Questionnaire was more than 80 at 1-year postoperatively. The appearance, oral competence, chewing, swallowing, speech and other oral functions were well recovered in about 90% of patients at 1-year postoperatively.
CONCLUSION: This new idea of reconstruction before tumour resection, brings the effect of plastic and reconstructive surgery to a new height.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Anterolateral thigh flap; Buccal squamous cell carcinoma; Oral cancer; Quality of life; Through-and-through cheek defects

Mesh:

Year:  2017        PMID: 29103740     DOI: 10.1016/j.oraloncology.2017.09.023

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  2 in total

1.  [Application of the nasolabial fold "smile" incision approach in posterior buccal cancer ablation].

Authors:  Tian Tian; Jie Chen; Ning Li; Long Huang; An-Jie Min; Xin-Qun Chen; Xin-Chun Jian; Can-Hua Jiang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2019-12-01

2.  Reconstruction of Complex Lateral Skull Base Defects After Oral Cancer Resection With Individualized Anterolateral Thigh Flap.

Authors:  Zhaojian Gong; Shanshan Zhang; Chang Chen; Yuan Zhi; Moxin Zi
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.